FI751700A7 - - Google Patents

Info

Publication number
FI751700A7
FI751700A7 FI751700A FI751700A FI751700A7 FI 751700 A7 FI751700 A7 FI 751700A7 FI 751700 A FI751700 A FI 751700A FI 751700 A FI751700 A FI 751700A FI 751700 A7 FI751700 A7 FI 751700A7
Authority
FI
Finland
Application number
FI751700A
Other languages
Finnish (fi)
Other versions
FI59408B (fi
FI59408C (fi
Inventor
Volkhard Austel
Eberhard Kutter
Joachim Heider
Wolfgang Eberlein
Rudolf Kadatz
Willi Diederen
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742427943 external-priority patent/DE2427943C2/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of FI751700A7 publication Critical patent/FI751700A7/fi
Publication of FI59408B publication Critical patent/FI59408B/fi
Application granted granted Critical
Publication of FI59408C publication Critical patent/FI59408C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI751700A 1974-06-10 1975-06-09 Foerfarande foer framstaellning av farmakologiskt vaerdefulla bensimidazoler FI59408C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2427943 1974-06-10
DE19742427943 DE2427943C2 (de) 1974-06-10 1974-06-10 Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2516040 1975-04-12
DE2516040A DE2516040C2 (de) 1974-06-10 1975-04-12 Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
FI751700A7 true FI751700A7 (enExample) 1975-12-11
FI59408B FI59408B (fi) 1981-04-30
FI59408C FI59408C (fi) 1981-08-10

Family

ID=25767253

Family Applications (1)

Application Number Title Priority Date Filing Date
FI751700A FI59408C (fi) 1974-06-10 1975-06-09 Foerfarande foer framstaellning av farmakologiskt vaerdefulla bensimidazoler

Country Status (23)

Country Link
US (1) US4026891A (enExample)
JP (1) JPS6015632B2 (enExample)
AT (1) AT342610B (enExample)
BE (1) BE830030A (enExample)
BG (2) BG23216A3 (enExample)
CA (1) CA1041095A (enExample)
CH (1) CH620438A5 (enExample)
CS (1) CS195292B2 (enExample)
DD (1) DD120440A5 (enExample)
DE (1) DE2516040C2 (enExample)
DK (1) DK258975A (enExample)
ES (2) ES437296A1 (enExample)
FI (1) FI59408C (enExample)
FR (1) FR2273545A1 (enExample)
GB (1) GB1466547A (enExample)
HU (1) HU171059B (enExample)
IE (1) IE41257B1 (enExample)
IL (1) IL47445A (enExample)
NL (1) NL178969C (enExample)
NO (1) NO142402C (enExample)
PH (1) PH14298A (enExample)
RO (1) RO68750A (enExample)
SE (1) SE420836B (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53117215A (en) * 1977-03-24 1978-10-13 Hideyoshi Morita Earthquakeeproof steel beam
ES482789A0 (es) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
US4258185A (en) * 1978-10-17 1981-03-24 Yoshitomi Pharmaceutical Industries, Ltd. Pyridazinone compounds
DE2935359A1 (de) * 1979-09-01 1981-03-26 Basf Ag, 67063 Ludwigshafen 6-imidazolyl-3-hydrazino-pyridazine
DE3006671A1 (de) * 1980-02-22 1981-08-27 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzoxazole, deren herstellung und deren verwendung als arzneumittel
US4699909A (en) * 1981-07-25 1987-10-13 Dr. Karl Thomae Gmbh Benzotriazolyl-4,5-dihydro-3(2H)-pyridazinones
DE3129447A1 (de) * 1981-07-25 1983-02-10 Dr. Karl Thomae Gmbh, 7950 Biberach "neue benztriazole, ihre herstellung und ihre verwendung als arzneimittel"
US4840955A (en) * 1984-12-24 1989-06-20 Warner-Lambert Company 6-substituted-2(1H)-quinolinones and related compounds having use as cardiotonic, antihypertensive, and antithrombotic agents
ZA859091B (en) * 1984-12-24 1987-07-29 Warner Lambert Co Novel 6-substituted-2 (1h)-quinolinones and related compounds having use as cardiotonic,anti-hypertensive,and anti-thrombotic agents
US4906630A (en) * 1985-11-22 1990-03-06 Rorer Pharmaceutical Corporation Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
US4725686A (en) * 1985-11-22 1988-02-16 William H. Rorer, Inc. Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses
US4868300A (en) * 1985-11-22 1989-09-19 Rorer Pharmaceutical Corporation Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses
US4785101A (en) * 1985-11-22 1988-11-15 Rorer Pharmaceutical Corporation Benzodiazinone-hydroxypyrazolyl compounds, cardiotonic compositions including the same and their uses
US4859672A (en) * 1986-10-29 1989-08-22 Rorer Pharmaceutical Corporation Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone
US5002944A (en) * 1986-10-29 1991-03-26 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having cardiotonic activity
JPS63181827U (enExample) * 1987-05-13 1988-11-24
DE4237656A1 (de) * 1992-06-13 1993-12-16 Merck Patent Gmbh Benzimidazolderivate
US6465484B1 (en) 1997-09-26 2002-10-15 Merck & Co., Inc. Angiogenesis inhibitors
US6162804A (en) * 1997-09-26 2000-12-19 Merck & Co., Inc. Tyrosine kinase inhibitors
EP1123703B1 (en) * 1998-10-23 2004-04-14 Toray Industries, Inc. Immunomodulatory drug composition
US20050119251A1 (en) * 2001-12-21 2005-06-02 Jian-Min Fu Nicotinamide derivatives and their use as therapeutic agents
US20030236259A1 (en) * 2002-02-05 2003-12-25 Rolf Hohlweg Novel aryl- and heteroarylpiperazines
CN101083982A (zh) 2004-09-20 2007-12-05 泽农医药公司 用于治疗硬脂酰CoA去饱和酶介导的疾病的杂环衍生物
CA2580857A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
WO2006034440A2 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CA2580844A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase
US7829712B2 (en) 2004-09-20 2010-11-09 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
JP5080256B2 (ja) * 2004-09-20 2012-11-21 ゼノン・ファーマシューティカルズ・インコーポレイテッド 二環式複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼ（ＳＣＤ）のインヒビターとしてのそれらの使用
AU2005286846A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
TW200624427A (en) * 2004-09-20 2006-07-16 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
JP4714921B2 (ja) * 2005-02-14 2011-07-06 トーアエイヨー株式会社 ピモベンダンの製造法及びその中間体
US8541457B2 (en) * 2005-06-03 2013-09-24 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
EP2386554A1 (en) * 2005-07-04 2011-11-16 High Point Pharmaceuticals, LLC Compounds active at the histamine H3 receptor
EP1915341A2 (en) 2005-08-15 2008-04-30 Irm, Llc Compounds and compositions as tpo mimetics
MX2008014766A (es) * 2006-05-29 2009-03-06 High Point Pharmaceuticals Llc 3-(1,3-benzodioxol-5-il)-6-(4-ciclopropilpiperazin-1-il)-piperazi na, sus sales y solvatos y su uso como antagonista del receptor de h3 histamina.
EP2014656A3 (en) * 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
US20120022057A1 (en) 2009-03-18 2012-01-26 Schering Corporation Bicyclic compounds as inhibitors of diacyglycerol acyltransferase
US8729263B2 (en) 2012-08-13 2014-05-20 Novartis Ag 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
MX383686B (es) * 2013-07-31 2025-03-14 Novartis Ag Derivados de piridazina 1,4-disustituida, y su uso para el tratamiento de afecciones relacionadas con la deficiencia de smn.
WO2018086703A1 (en) * 2016-11-11 2018-05-17 Bayer Pharma Aktiengesellschaft Dihydropyridazinones substituted with phenylureas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL23847A (en) * 1964-08-07 1969-02-27 Merck & Co Inc Benzimidazoles useful as antifungals
US3705157A (en) * 1970-10-19 1972-12-05 American Cyanamid Co Azolylpyridazine compounds and quaternary salts thereof
US3935209A (en) * 1973-03-12 1976-01-27 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
US3969526A (en) * 1973-05-29 1976-07-13 Smithkline Corporation Anthelmintic 5-heterocycliothio and oxy-2-carbalkoxyaminobenzimidazles

Also Published As

Publication number Publication date
AU8192675A (en) 1976-12-16
NO142402C (no) 1980-08-13
FI59408B (fi) 1981-04-30
IE41257L (en) 1975-12-10
FR2273545B1 (enExample) 1979-08-10
CA1041095A (en) 1978-10-24
JPS516980A (enExample) 1976-01-20
DE2516040A1 (de) 1976-11-04
GB1466547A (en) 1977-03-09
PH14298A (en) 1981-05-19
ES441340A1 (es) 1977-03-16
JPS6015632B2 (ja) 1985-04-20
FR2273545A1 (fr) 1976-01-02
ES437296A1 (es) 1977-01-01
NO142402B (no) 1980-05-05
RO68750A (ro) 1980-03-15
DE2516040C2 (de) 1984-12-20
BG23216A3 (bg) 1977-07-12
IE41257B1 (en) 1979-11-21
BE830030A (fr) 1975-12-09
FI59408C (fi) 1981-08-10
NL178969C (nl) 1986-06-16
CH620438A5 (enExample) 1980-11-28
DK258975A (da) 1975-12-11
ATA344575A (de) 1977-08-15
AT342610B (de) 1978-04-10
DD120440A5 (enExample) 1976-06-12
HU171059B (hu) 1977-10-28
SE7506583L (sv) 1975-12-11
SE420836B (sv) 1981-11-02
IL47445A0 (en) 1975-08-31
NL7506806A (nl) 1975-12-12
CS195292B2 (en) 1980-01-31
BG24052A3 (bg) 1977-12-15
IL47445A (en) 1978-07-31
US4026891A (en) 1977-05-31
NO752022L (enExample) 1975-12-11

Similar Documents

Publication Publication Date Title
FR2256812B1 (enExample)
FR2273545B1 (enExample)
FR2257322A1 (enExample)
FR2258528A1 (enExample)
FI751149A7 (enExample)
FR2258748A1 (enExample)
FR2258647A1 (enExample)
AU7891375A (enExample)
FI750279A7 (enExample)
DE2403726A1 (enExample)
CS172077B1 (enExample)
CS177293B1 (enExample)
CS167199B1 (enExample)
BG20471A1 (enExample)
BG20149A1 (enExample)
CH608910A5 (enExample)
CH585071A5 (enExample)
BG21778A1 (enExample)
BG20475A1 (enExample)
BG20473A1 (enExample)
DD119520A5 (enExample)
BG20462A1 (enExample)
DD123278A5 (enExample)
BG20455A1 (enExample)
BG20446A1 (enExample)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: DR. KARL THOMAE GESELLSCHAFT MIT